ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

NCI-Approved Trials Listed

April 28, 2006

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

Oncology Nursing Society Names 15 To Advisory Panel.

September 29, 2000

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007